Cargando…

Prostate-Specific Membrane Antigen-Based Therapeutics

Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to significant morbidity and mortality. While significant therapeutic advances have been made, available systemic therapeutic options are lacking. Prostate-specific membrane antigen (PSMA) is a highly-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akhtar, Naveed H., Pail, Orrin, Saran, Ankeeta, Tyrell, Lauren, Tagawa, Scott T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145341/ https://www.ncbi.nlm.nih.gov/pubmed/21811498 http://dx.doi.org/10.1155/2012/973820

Ejemplares similares

Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy
por: Kosuri, Satyajit, et al.
Publicado: (2012)

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer
por: Tagawa, Scott T., et al.
Publicado: (2013)

The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
por: Smith, Michael J., et al.
Publicado: (2012)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Plichta, Kristin A., et al.
Publicado: (2021)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Incidental prostate-specific membrane antigen-avid meningioma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2021)

Incidental prostate-specific membrane antigen-avid glioblastoma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2022)

Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane
por: Godeiro, Katyanne Dantas, et al.
Publicado: (2006)

More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond
por: Hyväkkä, Anniina, et al.
Publicado: (2021)

Isolation and characterization of circulating tumor cells in prostate cancer
por: Diamond, Elan, et al.
Publicado: (2012)

Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors
por: Stopa, Brittany M., et al.
Publicado: (2022)

Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management
por: Kessel, Katharina, et al.
Publicado: (2021)

The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities
por: Franzese, Elisena, et al.
Publicado: (2021)

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer
por: Wang, Xinning, et al.
Publicado: (2021)

Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review
por: de Kouchkovsky, Ivan, et al.
Publicado: (2021)

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
por: Hassani, Mahmoud, et al.
Publicado: (2020)

Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
por: Oh, So Won, et al.
Publicado: (2018)

Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer
por: Rosenfeld, Lior, et al.
Publicado: (2020)

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
por: Paschalis, Alec, et al.
Publicado: (2019)

Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer?
por: Ranjan, Satish Kumar
Publicado: (2020)

Prostate-Specific Membrane Antigen Expression in Neovasculature of Glioblastoma Multiforme
por: Mahzouni, Parvin, et al.
Publicado: (2019)

Diagnostic Role of Prostate-Specific Membrane Antigen in Adrenocortical Carcinoma
por: Gu, Yulin, et al.
Publicado: (2019)

Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer
por: Unger, Clara, et al.
Publicado: (2022)

Prostate-specific Membrane Antigen Based Antibody-drug Conjugates for Metastatic Castration-resistance Prostate Cancer
por: Niaz, Muhammad O, et al.
Publicado: (2020)

Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen
por: Dassie, Justin P, et al.
Publicado: (2014)

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells
por: Sommer, Ulrich, et al.
Publicado: (2022)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

State of the Art in Prostate-specific Membrane Antigen–targeted Surgery—A Systematic Review
por: Berrens, Anne-Claire, et al.
Publicado: (2023)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and Its Role in Salvage Lymph Node Dissection
por: Krimphove, Marieke J., et al.
Publicado: (2020)

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer
por: Ritawidya, Rien, et al.
Publicado: (2023)

Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
por: Lunger, Lukas, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?
por: Wächter, Sabine, et al.
Publicado: (2021)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer
por: Sharma, Satish, et al.
Publicado: (2022)

Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j6lvjjjjgq24fo3mk4ls2oehdp